Skip to main content
. 2014 Sep 5;232(5):931–942. doi: 10.1007/s00213-014-3728-6

Table 6.

Effect of subchronic administration of imperatorin (IMP; 1, 5, or 10 mg/kg, i.p.) and single scopolamine injection (SCP; 1 mg/kg, i.p.) on the seventh day, separately or in combination, on concentration of MDA in the cortex and hippocampus of mice. Data are presented as the means ± SEM; n = 8–12; *p < 0.05, **p < 0.01, ***p < 0.001 versus saline-treated control group, # p < 0.05, ### p < 0.001 versus scopolamine-treated control group, &p < 0.05, &&&p < 0.001 versus imperatorin-treated control group; Tukey’s test

Treatment MDA [μM/g wet w.]
Cortex Hippocampus
Saline 10.64 ± 0.13 3.454 ± 0.30
SCP 23.52 ± 0.69*** 6.187 ± 0.44***
IMP 1 mg/kg 12.34 ± 0.41 3.817 ± 0.25
IMP 1 mg/kg + SCP 19.59 ± 0.86###, &&& 5.582 ± 0.28
IMP 5 mg/kg 13.76 ± 0.51* 3.986 ± 0.33
IMP 5 mg/kg + SCP 18.63 ± 0.87###, &&& 5.699 ± 0.42#
IMP 10 mg/kg 14.30 ± 0.64** 4.196 ± 0.35
IMP 10 mg/kg + SCP 17.64 ± 0.57###, & 5.121 ± 0.29#
HHS Vulnerability Disclosure